Anthos Therapeutics Limited
Company Summary
Anthos Therapeutics Limited was set up on Wednesday the 10th of March 2021. Their current partial address is Dublin 2, and the company status is Liquidation. The company's current directors have been the director of 5 other Irish companies between them. Anthos Therapeutics Limited has 1 shareholder. This Irish company shares its Eircode with at least 199 other companies.
| Company Name: | Anthos Therapeutics Limited | |
| Company Status: | LIQUIDATION | |
| RiskWatch | Form E2: Notice of Appointment of Liquidator(s) Effective Date 23/10/2025 | |
| Company Address: | 1 Wml, 1 Windmill Lane, Dublin 2, Ireland | |
| Key Executive: | Ms Walsh | |
| Company Size: | Log-In To View | |
Key Contact Profile
Ms Walsh is a Company Director of Anthos Therapeutics Limited since 2025
Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.
Similar Companies - Create a marketing list of similar companies
Latest Updates
The latest documents filed with the Companies Registration Office for Anthos Therapeutics Limited (which can include the Account Details) are listed below.
| CRO Document | Effective Date | Received By CRO | View Now | |
|---|---|---|---|---|
| Form E2: Notice of Appointment of Liquidator(s) | 23/10/2025 | 02/03/2026 | Join Up | |
| Form G1 - Special Resolution to Wind up | 23/10/2025 | 02/03/2026 | Join Up | |
| E1-SAP Declaration of Solvency Summary App Procd | 23/10/2025 | 28/10/2025 | Join Up | |
| Form B1C - Annual Return General | 15/08/2025 | 15/08/2025 | Join Up | |
| Financial Statement Certificate | 15/08/2025 | 15/08/2025 | Join Up | |
| THIS COMPANY HAS 28 OTHER DOCS » | ||||
View CRO company documents and company reports any Irish company or business with ease.
Credit Report
View the Latest Credit Report and Credit Limit on Anthos Therapeutics Limited.
| Company Status: | Liquidation | |
| RiskWatch | Form E2: Notice of Appointment of Liquidator(s) Effective Date 23/10/2025 | |
| Latest Credit Movement: |  | |
| Date of Last Movement: | 03/03/2026 | |
| Latest Accounts Filed: | 15/08/2025 | |
| Report Based on Accounts: | 31/12/2024 | |
| Next Set of Accounts Due: | 30/09/2026 | |
| Overdue: | No | |
| Credit Score: | Join-Up to View | |
Full Credit Rating
To View the latest Credit Rating or Credit Limit on Anthos Therapeutics Limited simply click 'Log-In' or 'Join-Up' below.
Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.
Directors & Owners
Satisfy due diligence requirements on Anthos Therapeutics Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Anthos Therapeutics Limited and Anti-Money Laundering checks (AML checks) on Anthos Therapeutics Limited
Directors details are available to logged in users.
Ownership Structure
| Company Type: | LTD - Private Company Limited By Shares |
| Number of Shareholders: | 1 |
Compliance
Log-in now to run Due Diligence checks and Compliance checks on Anthos Therapeutics Limited or click Join-up to get started.
Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.
Ask Us A Question...?
More people choose Vision-net over any other search service... ask us why?
Ireland's Business Insights Report
27/02/2026
Insights into Start-Up Resilience, Market Challenges and the Changing Risk Environment...
Extend Access to Your Team - At No Extra Cost
16/02/2026
To support smoother collaboration across your business, we're making it easier your colleagues
NACE Rev. 2.1: What the 2026 Update Means for Your Reporting
09/02/2026
From 1 January 2026, EU authorities require institutions to report counterparty economic activity using the updated NACE Rev.2.1 classification.
Commercial Judgments Up 67% as Insolvencies Shift Toward Older Firms
03/02/2026
While 2025 data highlights sustained momentum in new company formation (26,500 start-ups), emerging indicators point to growing financial strain across the corporate sector.